Important note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
PRNewswire - December 2, 2003
"We are very pleased to have the opportunity to meet with the Senior health officials and to review with them our progress regarding regulatory approval. The SDA application has been filed and both laboratory and live testing started several weeks ago. We also look forward to visiting the recently established local offices for the marketing and support of the VScan test kits," stated Robert Talbot.
In addition to the meeting with senior health officials, meetings have been arranged with the Chinese Health Management Organization (HMO) who represents hospitals in 12 provinces and has issued the Company a letter of intent that could easily represent a potential first year volume of 3,000,000 to 5,000,000 HIV test kits.
Medical Services is the first Company that has signed an agreement with a Chinese Distribution Company that has a Distribution License to distribute HIV test kits. Test kits for HIV cannot be sold in China without a Distribution License even if approval is received by regulatory agencies.
Medical Services is the only HIV test kit that has applied for approval based on both HIV 1&2. The company's test kit uses whole blood, serum and plasma and does not require refrigeration, specialized medical equipment or trained medical personnel. This makes it ideal for testing in remote areas.
The company has been advised that whole blood is the preferred method of testing as it can be done on the spot with immediate results. The live testing done in Florida and in other locations has shown that the VScan test kit is very accurate and easy to use in the field using whole blood.
About VScan
The VScan rapid test kit is a single use, disposable, accurate (greater than 99%), cost effective, easy to use test for the screening of HIV 1&2 and subgroup O, Hepatitis B&C, and Tuberculosis (TB). The kits cannot be sold in Canada.
Medical services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or Bill Whitehead Jr. at (416) 822 5883 or http://www.medicalservicesintl.com .
NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.
SOURCE Medical Services International Inc.
Web Site: http://www.medicalservicesintl.com
031202
PR031206
Copyright © 2003 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .